These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5456013)

  • 21. Rubidium release: a rapid and sensitive assay for amphotericin B.
    Drazin RE; Lehrer RI
    J Infect Dis; 1976 Sep; 134(3):238-44. PubMed ID: 789783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of high-performance liquid chromatography and bioassay of amphotericin B in serum.
    Hülsewede JW; Dermoumi H
    Mycoses; 1994; 37(1-2):17-21. PubMed ID: 7935586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amphotericin B: an introduction.
    Warnock DW
    J Antimicrob Chemother; 1991 Oct; 28 Suppl B():27-38. PubMed ID: 1778890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Amphotericin B: the end of an era].
    Oude Lashof AM; Kullberg BJ
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1665-8. PubMed ID: 15453116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and adverse effects of amphotericin B in infants and children.
    Koren G; Lau A; Klein J; Golas C; Bologa-Campeanu M; Soldin S; MacLeod SM; Prober C
    J Pediatr; 1988 Sep; 113(3):559-63. PubMed ID: 3411404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B.
    Kaspar RL; Drutz DJ
    Antimicrob Agents Chemother; 1975 Apr; 7(4):462-5. PubMed ID: 1096801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progress in the therapy of systemic mycoses].
    Plempel M
    Verh Dtsch Ges Inn Med; 1978; (84):443-52. PubMed ID: 369201
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid infusion of amphotericin B: is it safe, effective, and wise?
    Schuler U; Ehninger G
    Am J Med; 1995 Jul; 99(1):104-5. PubMed ID: 7598128
    [No Abstract]   [Full Text] [Related]  

  • 29. Amphotericin B. Old drug, new therapy.?2110.
    Medoff G; Kobayashi GS
    JAMA; 1975 May; 232(6):619-20. PubMed ID: 1091753
    [No Abstract]   [Full Text] [Related]  

  • 30. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.
    Maharom P; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphotericin B versus amphotericin B plus 5-flucytosine: poor results in the treatment of proven systemic mycoses in neutropenic patients.
    Verweij PE; Donnelly JP; Kullberg BJ; Meis JF; De Pauw BE
    Infection; 1994; 22(2):81-5. PubMed ID: 8070935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate.
    Collette N; van der Auwera P; Lopez AP; Heymans C; Meunier F
    Antimicrob Agents Chemother; 1989 Mar; 33(3):362-8. PubMed ID: 2658785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients.
    Lombardi G; Gramegna G; Cavanna C; Michelone G
    Microbiologica; 1990 Jul; 13(3):201-6. PubMed ID: 2273982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brief report: practicability and safety of amphotericin B deoxycholate as continuous infusion in neutropenic patients with hematological malignancies.
    Schulenburg A; Sperr W; Rabitsch W; Knöbl P; Thalhammer F
    Leuk Lymphoma; 2005 Aug; 46(8):1163-7. PubMed ID: 16085557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology, toxicity, and therapeutic usefulness of amphotericin B.
    Butler WT
    JAMA; 1966 Jan; 195(5):371-5. PubMed ID: 5951895
    [No Abstract]   [Full Text] [Related]  

  • 36. The combination of amphotericin B and azithromycin as a potential new therapeutic approach to fusariosis.
    Clancy CJ; Nguyen MH
    J Antimicrob Chemother; 1998 Jan; 41(1):127-30. PubMed ID: 9511049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of activity of amphotericin B in systemic murine fusarial infection.
    Anaissie EJ; Hachem R; Legrand C; Legenne P; Nelson P; Bodey GP
    J Infect Dis; 1992 Jun; 165(6):1155-7. PubMed ID: 1583339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current role of amphotericin B in the treatment of deep mycoses].
    Dei-Cas E; Ajana F; Deldicque P; Bonaly R; Vernes A
    Ann Biol Clin (Paris); 1987; 45(6):673-9. PubMed ID: 3326439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elution of High Dose Amphotericin B Deoxycholate From Polymethylmethacrylate.
    Houdek MT; Greenwood-Quaintance KE; Morrey ME; Patel R; Hanssen AD
    J Arthroplasty; 2015 Dec; 30(12):2308-10. PubMed ID: 26162513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains.
    Witt MD; Imhoff T; Li C; Bayer AS
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2030-2. PubMed ID: 8239628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.